What Evolution Research Group does

Evolution Research Group (ERG) is a US-based private contract research organization (CRO) that operates a network of 11 independently-branded clinical research facilities across six states (Arkansas, California, Florida, Ohio, New York, and Texas). Founded in 2014 and headquartered in New Providence, ERG conducts Phase I-IV clinical trials for pharmaceutical and biotech sponsors across therapeutic areas including psychiatric disorders, pain, Alzheimer's disease, hepatic impairment, renal impairment, addiction, and other debilitating conditions. The network is anchored by site brands such as Brain Matters Research, Clinical Pharmacology of Miami, Endeavor Clinical Trials, HD Research, Neuropsychiatric Research Center of Southwest Florida, Ohio Clinical Trials, Synergy Research Centers, Woodland International Research Group, Richmond Behavioral Associates, and Midwest Clinical Research Center.

ERG's core technology layer is the MyTrialApp mobile application (Version 2 released in 2025), which manages patient participation through notifications, schedule management, a Refer-a-Friend program, and a native Uber integration for transportation to trial visits. The company operates a direct-to-consumer recruitment model, using its joinaresearchstudy.com website, the MyTrialApp, and community outreach to enroll both patients with qualifying medical conditions and healthy volunteers. Patients and healthy volunteers participate at no cost and are compensated for their time, while revenue is generated through contracted research services paid by pharmaceutical and biotech sponsors, likely on a per-study or master service agreement basis.

The business is built on a roll-up of site acquisitions, including the 2017 purchases of Brain Matters Research and Endeavor Clinical Trials, and continues to add owned capacity, most recently opening a new state-of-the-art Clinical Pharmacology of Miami facility in October 2025. Lori T. Wright serves as Founder and CEO, with operational leadership distributed across site-level principal investigators and clinical pharmacology specialists such as Clay Dehn (VP of Clinical Pharmacology Services at Endeavor). No public ownership, funding history, or financial disclosures are available, and pricing for sponsor services is not publicly listed.

Name

Evolution Research Group

Legal name

Evolution Research Group

Website

https://evolutionresearchgroup.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

251–500 employees

Short description

Evolution Research Group is a private US contract research organization operating 11 clinical research facilities across 6 states, conducting Phase I-IV trials in psychiatry, pain, Alzheimer's, hepatic, and renal indications for pharmaceutical and biotech sponsors via its MyTrialApp patient platform.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Contract Research Organization)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Patient recruitment platform
• Phase I-IV trials

Headquarters

HQ city

New Providence

HQ country

United States

HQ region

North America

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Services for Sponsors: Conducts clinical trials on behalf of pharmaceutical companies, biotech firms, and other research sponsors. Revenue is generated through contracted research services, likely billed per study or through master service agreements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Evolution Research Group is a Contract Research Organization that conducts Phase I–IV clinical trials on behalf of pharmaceutical and biotech sponsors through a network of more than 10 owned research sites in Arkansas, California, Florida, Ohio, New York, and Texas. Its trials span psychiatric disorders, pain, Alzheimer's disease, hepatic and renal impairment, addiction, ADHD, and other debilitating conditions. Patients and healthy volunteers are recruited through a consumer-facing website (joinaresearchstudy.com), a mobile application (MyTrialApp), and Refer-a-Friend outreach.

Product overview

Evolution Research Group operates as a clinical research organization with a network-centric architecture consisting of a patient-facing mobile application (MyTrial App) and a network of 11 independently-branded research facilities across 6 states. The MyTrial App serves as the central digital platform for patient engagement, enabling study participation management, appointment scheduling, transportation coordination via Uber integration, and referral functionality. The facility network, spanning Arkansas, California, Florida, Ohio, New York, and Texas, collectively conducts Phase I-IV clinical trials across therapeutic areas including psychiatric disorders, pain, Alzheimer's, hepatic diseases, renal diseases, and various other debilitating conditions. The company positions itself as one of the largest research organizations in the nation focusing on clinical trials for both healthy individuals and those with medical conditions.

Differentiator

Problem solved

Functional benefit

Brands

• MyTrialApp: Mobile application for managing study participation, featuring patient notifications, Uber integration, refer-a-friend, and schedule management.

Products and services

• MyTrial App (Version 2) A mobile application (iOS and Android) for patients and healthy volunteers participating in clinical trials at ERG network sites, providing patient notifications, schedule management, Uber-based transportation booking to trial appointments, and Refer-a-Friend recruitment functionality.
• Clinical Research Facility Network (Phase I-IV Trial Services) A nationwide network of 10+ owned clinical research facilities that conduct Phase I-IV clinical trials on behalf of pharmaceutical and biotech sponsors across therapeutic areas including psychiatric disorders, pain, Alzheimer's disease, hepatic and renal impairment, addiction, ADHD, depression, schizophrenia, and other debilitating conditions. Recruiting sites include Brain Matters Research (Delray Beach & Stuart, FL), Clinical Pharmacology of Miami (Miami, FL), Endeavor Clinical Trials (San Antonio, TX), HD Research (Houston/Bellaire & Dallas/Carrollton, TX), Neuropsychiatric Research Center of Southwest Florida (Fort Myers, FL), Ohio Clinical Trials (Columbus, OH), Richmond Behavioral Associates (Staten Island, NY), Synergy Research Centers (Lemon Grove, CA), Woodland International Research Group (Little Rock, AR), Woodland Research Northwest (Rogers, AR), and Midwest Clinical Research Center (Dayton, OH).

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• CenExel: CenExel is a private equity-backed SMO network operating ~10 research centers across the US focused on Phase I–IV clinical trials in CNS, analgesia, and early-phase clinical pharmacology. Most directly comparable to ERG in therapeutic mix, multi-site model, and patient-recruitment playbook.
• Flourish Research: Flourish Research is a multi-site clinical research network operating across the US, formed through acquisitions of independent sites. Directly comparable to ERG's roll-up structure, wholly-owned subsidiary model, and therapeutic breadth including psychiatry and CNS trials.
• Apex Innovative Sciences: Apex Innovative Sciences operates a US network of clinical research sites with focus on early-phase, Phase I, and clinical pharmacology studies. Highly comparable to ERG's Phase I/clinical pharmacology positioning (e.g., CPMI).
• CTI Clinical Trial & Consulting Services: CTI is a privately held CRO with strong therapeutic focus in rare/orphan diseases, hematology, and immunology. Comparable as a privately held, mid-size CRO serving pharma sponsors across multiple therapeutic areas.

Broad incumbents

• Medpace: Medpace is a publicly traded mid-sized global CRO with strong therapeutic focus in oncology, metabolic, and CNS. Comparable to ERG in mid-size CRO economics and therapeutic concentration, though Medpace operates globally and at materially larger scale.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO with deep CNS, cardiometabolic, and rare disease experience. Comparable in mid-tier CRO positioning and therapeutic mix; differentiated by broader international footprint.
• IQVIA: IQVIA is the largest global CRO with full-service clinical, data, and site solutions capabilities. Relevant as a competing CRO for sponsor mindshare and trial allocation, though far larger and broader in scope than ERG.
• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization combining CRO and commercial services. Comparable as a CRO competitor for sponsor trials in ERG's therapeutic areas; differs in global scale and commercial-services breadth.
• ICON plc (incl. PRA Health Sciences): ICON is a top-3 global CRO offering full-service clinical development including site management through dedicated units. Comparable as a competing full-service and SMO provider for pharma sponsors; significantly larger and more global than ERG.

Emerging players

• Benchmark Research: Benchmark Research operates multiple US clinical research sites with focus on vaccine, infectious disease, and general therapeutic trials. Comparable as a smaller US-based multi-site research network with similar site-network economics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ERGResearch
• Facebookfacebook.com/ergresearch
• LinkedInlinkedin.com/company/evolution-research-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evolution Research Group